In the BioHarmony Drug Report Database

"Preview" Icon

Prochlorperazine

Compazine (prochlorperazine) is a small molecule pharmaceutical. Prochlorperazine was first approved as Compazine on 1982-01-01. It is used to treat anxiety disorders, dementia, nausea, psychotic disorders, and schizophrenia amongst others in the USA. The pharmaceutical is active against D(2) dopamine receptor and D(3) dopamine receptor. In addition, it is known to target D(1A) dopamine receptor, D(4) dopamine receptor, and protein S100-A4.

 

Trade Name

 

Compazine
 

Common Name

 

prochlorperazine
 

ChEMBL ID

 

CHEMBL728
 

Indication

 

anxiety disorders, dementia, nausea, psychotic disorders, schizophrenia, vomiting
 

Drug Class

 

Typical antipsychotic

Image (chem structure or protein)

Prochlorperazine structure rendering